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ABSTRACT adb_360 694..705
The neuropeptide galanin and its three receptor subtypes (GalR1-3) are expressed in the central amygdala (CeA), a
brain region involved in stress- and anxiety-related behaviors, as well as alcohol dependence. Galanin also has been
suggested to play a role in alcohol intake and alcohol dependence.We examined the effects of galanin in CeA slices from
wild-type and knockout (KO) mice deficient of GalR2 and both GalR1 and GalR2 receptors. Galanin had dual effects on
gamma-aminobutyric acid (GABA)-ergic transmission, decreasing the amplitudes of pharmacologically isolated
GABAergic inhibitory postsynaptic potentials (IPSPs) in over half of CeA neurons but augmenting IPSPs in the others.
The increase in IPSP size was absent after superfusion of the GalR3 antagonist SNAP 37889, whereas the IPSP
depression was absent in CeA neurons of GalR1 ¥ GalR2 double KO and GalR2 KO mice. Paired-pulse facilitation
studies showedweak or infrequent effects of galanin on GABA release. Thus, galaninmay act postsynaptically through
GalR3 to augment GABAergic transmission in some CeA neurons, whereas GalR2 receptors likely are involved in the
depression of IPSPs. Co-superfusion of ethanol, which augments IPSPs presynaptically, together with galanin caused
summated effects of ethanol and galanin in those CeA neurons showing galanin-augmented IPSPs, suggesting the two
agents act via differentmechanisms in this population. However, in neurons showing IPSP-diminishing galanin effects,
galanin blunted the ethanol effects, suggesting a preemptive effect of galanin. These findingsmay increase understand-
ing of the complex cellular mechanisms that underlie the anxiety-related behavioral effects of galanin and ethanol in
CeA.
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INTRODUCTION
Galanin is a C-terminally amidated peptide of 29 amino
acids in rodents that binds with high affinity to all three
known galanin receptors (GalR1–3) belonging to the cat-
egory of G-protein coupled receptors (GPCRs). Galanin-
like immunoreactivity is widely distributed in the central
nervous system, including the dorsal raphe nucleus
(DRN), the locus coeruleus (LC), the central amygdala
(CeA), several hypothalamic nuclei and the cholinergic
cell bodies of nucleus basalis of Meynert (Melander et al.
1986). Galanin coexists with norepinephrine in the CeA
and several other brain regions (Melander et al. 1986),
and galanin binding sites or expression corresponding to
GalR1, GalR2 and GalR3 are observed in the CeA
(Melander et al. 1988). The CeA is implicated in several
behaviors such as those related to fear, stress, anxiety and
alcohol dependence (see e.g. Davis, Rainnie & Cassell
1994; Pich et al. 1995; Roberto et al. 2010b). This
nucleus contains a high proportion of gamma-
aminobutyric acid (GABA)-containing neurons (Cassell,
Gray & Kiss 1986; Cassell, Freedman & Shi 1999) and is
known to be involved in substance abuse and dependence
(see e.g. Roberto et al. 2010b).
However, to our knowledge, there are no reports of
electrophysiological effects of galanin on CeA neurons,
despite behavioral studies suggesting that the galanin
system in this nucleus could be important for the
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treatment of anxiety (Moller et al. 1999; Khoshbouei
et al. 2002). Effects of galanin have been studied electro-
physiologically in several other brain regions. For
example, galanin inhibits muscarinic excitatory postsyn-
aptic potentials in the hippocampus via presynaptic
galanin receptors inhibiting acetylcholine release (Fisone
et al. 1987; Dutar, Lamour & Nicoll 1989). Galanin also
excites dorsal root ganglia neurons (Kerekes et al. 2003),
but hyperpolarizes noradrenergic neurons in LC (Pieri-
bone et al. 1995; Ma et al. 2001). Galanin 2-11 (Gal
2-11), a GalR2-selective agonist, had no effect on LC
neurons (Pieribone et al. 1995; Xu, Tong & Hokfelt
2001). In a recent study from our laboratory, in most
DRN neurons, both galanin 2-11 and galanin 1-29
markedly decreased the amplitude of evoked GABAergic
inhibitory postsynaptic potentials (IPSPs) (Sharkey et al.
2008). Paired-pulse facilitation (PPF) studies suggested
that the galanin 1-29 effect was elicited presynaptically
by reducing GABA release.
In addition to its suggested role in anxiety and depres-
sion (Swanson et al. 2005; Ogren et al. 2006; Lu, Sharkey
& Bartfai 2007), galanin and its receptors also have been
reported to play some role in food and ethanol consump-
tion (Leibowitz et al. 2003; Lewis et al. 2004; Chang et al.
2007; Karatayev, Baylan & Leibowitz 2009; Karatayev
et al. 2010) as well as opiate reinforcement (Picciotto
et al. 2005). Thus, in rodents, intraventricular injection
of galanin or galanin overexpression increases alcohol
intake, whereas a galanin knockout (KO) decreases
ethanol intake (Lewis et al. 2004; Chang et al. 2007;
Karatayev et al. 2009, 2010); furthermore, ethanol
intake increases galanin mRNA in the hypothalamus
whereas ethanol withdrawal decreases it (Leibowitz et al.
2003).
Therefore, the present studies were designed to clarify
the role of galanin and its receptors in the CeA and
increase understanding of the role of CeA in stress,
anxiety and ethanol effects. Our results suggest that
galanin alters the electrophysiological properties of CeA
neurons in a dual manner that may explain the reported
mixed effects of intra-CeA galanin microinjection in
anxiety tests in rodents (Moller et al. 1999; Khoshbouei
et al. 2002). We find no postsynaptic effect of galanin on
averaged voltage–current (V/I) curves, but it significantly
alters the amplitude of evoked IPSPs in a dual manner
probably involving multiple GalR subtypes. Our PPF
studies suggest that these galanin effects may be
explained by a postsynaptic action on GABA receptor
function in some CeA neurons, but a small presynaptic
effect in others. In addition, because we previously
showed that superfusion of ethanol and the anxiety/
stress-related peptide corticotrophin-releasing factor
(CRF) both elicit the somewhat paradoxical effect of aug-
menting GABAergic IPSPs in CeA neurons (Roberto et al.
2003, 2010b; Nie et al. 2004), we also examined the
effects of co-applied ethanol on the responses to galanin
in CeA neurons and found complex interactions depend-
ing upon CeA neuron responses to galanin.
METHODS
Slice preparation
We prepared brain slices containing CeA from male
C57Bl/6J mice (25–30 g) that were anesthetized with
isoflurane (3%) and decapitated, as previously described
(Roberto et al. 2003, 2010b; Nie et al. 2004). GalR1 and
GalR2 double KO mice were obtained by crossing the
GalR1 KO (Mitsukawa, Lu & Bartfai 2009) with GalR2
KO (Lu et al. 2008) mice. With the investigator blind to
the mouse strain/genetics, the brains were rapidly
removed and placed into ice-cold artificial cerebrospinal
fluid (ACSF) gassed with 95% O2 and 5% CO2. We cut
transverse slices 400 mm thick on a LeicaVT 1000S
vibrating slicer (Leica Microsystems Inc., Buffalo Grove,
IL, USA), incubated them in an interface configuration
for about 30 minutes and then completely submerged
and continuously superfused (flow rate of 2–4 ml/
minute) them with warm (31°C), O2/CO2-gassed ACSF of
the following composition in mM: NaCl, 130; KCl, 3.5;
NaH2PO4, 1.25; MgSO4·7H2O, 1.5; CaCl2, 2.0; NaHCO3,
24; glucose, 10. The inner chamber had a total volume of
0.8 ml; at the 2–4 ml/minute superfusion rates used,
90% replacement of the chamber solution could be
obtained within 1 minute. We added drugs to the ACSF
from stock solutions to obtain known concentrations in
the superfusate.
Electrophysiology
We recorded from CeA neurons with sharp micropi-
pettes containing 3 M KCl (65–80 mW resistance)
using current-clamp mode. Data were acquired with
an Axoclamp-2A preamplifier [Axon Instruments (now
Molecular Devices, Sunnyvale, CA, USA)] and stored for
offline analysis via pClamp software (Molecular Devices).
We evoked pharmacologically isolated GABAAergic
IPSPs by stimulating locally within the medial subdivi-
sion of the CeA with a bipolar stimulating electrode,
while continuously superfusing the glutamate receptor
blockers 6,7-dinitroquinoxaline-2,3-dione (DNQX; 20
mM) and DL-2-amino-5-phosphonopentanoic acid (DL-
AP5, 30 mM), and the GABAB antagonist CGP 55845A
(1 mM).
We held the CeA neurons near their resting mem-
brane potentials (RMPs), which ranged between -64 and
-84 mV (mean: -78.6  0.7 mV, n = 73), and applied
hyperpolarizing and depolarizing current steps (200 pA
increments, 750 ms duration) to generate V/I curves. To
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determine half-maximal IPSP amplitudes, we examined
input/output (I/O) curves by measuring evoked IPSP
amplitudes at five stimulus strengths, threshold to
maximum stimulation. Subsequent analyses were done
with averages of two IPSPs evoked with half-maximal
stimuli. We measured the IPSP amplitudes before
(control), during and after (washout) drug application,
andwe determined the percent change in IPSP amplitude
at each stimulus intensity by the equation (Vdrug/
Vcontrol) * 100. The criteria for accepting a galanin or
ethanol effect on IPSP amplitudes were a change of
 10% of control at the half-maximal stimulus intensity
over the 8- to 15-minute superfusion time points and
following galanin/ethanol washout (10–25 minutes).
We examined PPF in multiple neurons using 100 ms
interstimulus intervals and stimulus strength adjusted so
that the amplitude of the first IPSP was 50% of maximal
amplitude determined from the I/O relationship. We cal-
culated PPF as the ratio of the second IPSP amplitude
over that of the first IPSP, multiplied by 100. For PPF
experiments, we took measurements before galanin or
ethanol superfusion (control), during (8–15 minutes)
and after galanin/ethanol washout (10–25 minutes).
We express all values asmean  standard error of the
mean. Statistical analysis was performed with GraphPad
Prism 5.0 software (GraphPad Software, San Diego, CA,
USA). We analyzed the data using a one-way analysis of
variance followed by a Dunnett’s and Bonferroni post hoc
test; P < 0.05 was considered statistically significant. In
some cases, we also used Student’s paired t-test; again,
P < 0.05 was considered statistically significant.
Drugs
CGP 55845A was a gift from Novartis Pharma, Basel
Switzerland. We purchased DL-AP5 and DNQX from
Tocris Tocris-Bioscience (Ellisville, MO, USA) and bicu-
culline from Sigma-Aldrich (St Louis, MO, USA). Galanin
(Gal 1-29; GWTLNSAGYLLGPHAIDNHRSFSDKHGLT
amide) was synthesized by Biopeptide (San Diego, CA,
USA) and theGalR3 antagonist SNAP37889was synthe-
sized by EdwardRoberts atThe Scripps Research Institute.
We obtained ethanol from Remet (La Mirada, CA, USA).
RESULTS
CeA neuron sample
We recorded from a total of 85 mouse CeA neurons and,
for some of the ethanol-galanin studies, four rat CeA
neurons. In our CeA slices, all cells were quiescent. The
mean RMP was -78.6  0.7 mV. Most neurons in the
CeA appear to contain GABA, and may be either inter-
neurons or projection neurons (Cassell et al. 1986,
1999). Therefore, the effects of galanin were initially
assessed on the membrane properties and GABAergic
IPSPs in these cells by superfusing a maximal 1 mM con-
centration of galanin (see Methods).
Little galanin effect on postsynaptic membrane
properties in CeA neurons
We fully analyzed 23mouse CeA neurons for the effects of
superfused galanin (1 mM) on voltage/current measure-
ments. Interestingly, in all cells so tested from the medial
subdivisionof themouseCeA, andas shownby thevirtual
superposition of averaged V/I curves, we found no signifi-
cant effect of 1 mM galanin on these V/I curves (Fig. 1),
whether they were recorded from wild-type (WT) litter-
mate controls or GalR2 KO mice (Fig. 1a), or from
GalR1 ¥ GalR2 KO mice or their WT littermate controls
afterblockof GalR3withSNAP37889(SNAP;Fig. 1b; see
following discussion). SNAPwas used to rule out the pos-
sibility that actions on GalR3 receptors might counteract
actions of GalR1 or 2 on membrane conductance. As a
first approximation, these findings suggest that galanin
has little or no effect on membrane conductance in CeA
neurons over a wide range of membrane potentials.
Galanin decreases GABAA-IPSP amplitudes in a
subpopulation of catecholamine neurons
We assessed the effects of galanin on pharmacologically
isolated GABAA-IPSPs evoked from CeA neurons by a
stimulating electrode placed in the medial subdivision of
the CeA. In our initial studies on CeA neurons from
normal WT C57Bl/6 and WT littermate mice (of GalR2
and GalR1 ¥ GalR2) using a relatively long superfusion
time (8–15 minutes), a maximal concentration of
galanin (1 mM) significantly (P < 0.001) decreased the
mean-evoked IPSP amplitudes, in 11 of the 23 mouse
CeA neurons studied (Fig. 2a, c), to a mean of 72% of
control. In another subpopulation of five WT CeA
neurons pretreated with SNAP to block GalR3 receptors,
galanin still significantly (P = 0.008) decreased IPSP size
(Fig. 3).
Galanin increases evoked IPSP amplitudes in another
CeA subpopulation
In many WT CeA neurons galanin (1 mM) superfusion
elicited an increase in IPSP amplitudes that was some-
what smaller but developed earlier (5–9 minutes) than
the IPSP decrease seen in the neuronal population
described above. The pooled data from 12 of 23 CeA cells
from WT and littermate mice revealed that the mean
evoked IPSP amplitude at half-maximal stimulus inten-
sity was significantly increased (to 114% of control,
n = 12; P < 0.05) by galanin superfused for 5–9 minutes
(Fig. 2b & d). In both populations of neurons, subsequent
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superfusion of 30 mM bicuculline for 5 minutes usually
completely abolished or greatly reduced the evoked IPSPs
(Fig. 2b), demonstrating that they were dependent on
GABAA receptor activation.
Galanin has only weak, variable effects on PPF of
evoked IPSPs
To initially assess the site of action for galanin in decreas-
ing GABAA-IPSP amplitudes, we examined its effect on
PPF of IPSPs in CeA neurons. PPF, as determined from
the paired-pulse ratio, has been shown to vary inversely
with the presynaptic release of transmitter (Mennerick &
Zorumski 1995; Salin, Malenka & Nicoll 1996; Bonci &
Williams 1997). In brief, our paired-pulse studies showed
highly variable or no effects of galanin on PPF of IPSPs in
most CeA neurons of WT, GalR1 ¥ GalR2 KO or their
littermate control mice; when averaged according to the
galanin effect on IPSP increases or decreases, there was
no significant effect (data not shown). PPF was signifi-
cantly changed (increased) by galanin only in CeA
neurons of GalR2 KO mice, and only at the early super-
fusion time point (data not shown), despite the apparent
lack of effect of galanin on IPSP amplitudes in this set of
CeA neurons. Because our V/I studies showed no effect of
galanin on membrane properties, these findings suggest
that the changes in IPSP amplitudes might arise in most
CeA neurons from modulation of postsynaptic GABAA
receptors.
A GalR3 antagonist and GalR KOs differentially block
the dual galanin effects
To assess the possible role of GalR subtype-dependent
effects in the dual actions of galanin in CeA, we usedmice
with KO constructs of either GalR2 receptors alone or
mice with KOs of both GalR1 and Gal2 receptors
(GalR1 ¥ GalR2 KOs). As mice with KOs of GalR3 recep-
tors are not yet available, we also used one of the recently
developed antagonists of these receptors (SNAP 37889;
Ogren et al. 1992; Swanson et al. 2005) to block the
GalR3 receptors pharmacologically.
Figure 1 Galanin has little effect on
voltage/current (V/I) relationships in
central amygdala (CeA) neurons. (a)
CeA neurons from the GalR2 knockout
(KO) and their wild-type (WT) littermate
controls. Galanin 1 mM had no effect on
theV/I relationships in CeA neurons from
either control (n = 5) or GalR2 KO
(n = 6) mice. (b) CeA neurons from
GalR1 ¥GalR2 double KO mice and their
littermate controls. Galanin 1 mM in the
presence of the GalR3 antagonist SNAP
37889 (SNAP, 200 nM) had no effect on
theV/I relationships in CeA neurons from
either control (n = 6) or GalR1 ¥GalR2
double KO (n = 6) mice.These data show
that galanin has no effect on resting
potential (dashed lines) in CeA, and as
well they suggest little effect on voltage-
dependent conductance. Each cell was
recorded with sharp electrodes (filled
with 3M KCl) in current-clamp mode to
obtain sweeps of electrotonic responses
(V) to incrementally increasing current-
step injections (I). Dashed lines indicate
resting membrane potential (no holding
current)
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Thus, in an initial set of five CeA neurons fromnormal
WT mice, we assessed the effect of SNAP 37889 on the
two types of responses of evoked IPSP amplitudes to
galanin. As shown in Fig. 3, after superfusion of 200 nM
SNAP 37889, subsequent co-perfusion of 1 mM galanin
had only depressant effects on IPSP amplitudes, suggest-
ing that the IPSP augmentations and not the IPSP
depressions involve GalR3 activation.
In initial studies using GalR KO mice, of five CeA
neurons from the double GalR1 ¥ GalR2 KO mice, four
cells showed a clear galanin-evoked increase of IPSPs,
suggesting involvement of GalR3, whereas one cell
showed little change. No cells showed galanin-induced
decreases of IPSP amplitudes. The mean IPSP increase
for all five cells during galanin superfusion was
114  5% of control, a significant effect (P < 0.05),
again suggesting that the IPSP-augmenting galanin
effect in WT mice may involve GalR3 receptors in most
cells.
In another experiment, superfusing SNAP 37889
together with galanin onto CeA neurons of GalR1
¥ GalR2 KO and WT littermate controls (n = 7 and 8,
respectively), SNAP prevented the IPSP increase but
not the IPSP decrease in the WT littermate CeA
neurons (Fig. 4). However, there was no signifi-
cant galanin-induced effect on the IPSPs in the
GalR1 ¥ GalR2 KO neurons superfused with SNAP
37889. We conclude that the IPSP depression is absent
in the CeA of double KO mice, but not in that of the
WT littermates, even in the presence of the SNAP
Figure 2 Brief galanin applications both decrease (a) and increase (b) the amplitudes of evoked gamma-aminobutyric acid (GABA)A
inhibitory postsynaptic potentials (IPSPs) in different central amygdala (CeA) neuron populations. (a, b) Representative voltage traces (using
half-maximal stimulus intensities) of evoked GABAA-IPSPs from CeA neurons before (Control), during (Gal) and after (Wash) superfusion of
1 mM galanin for 5–8minutes. (a) Galanin superfusion depresses IPSP amplitudes in this CeA neuron with recovery on washout of galanin. (b)
In another CeA neuron, galanin superfusion augments IPSP amplitudes with recovery on washout. Note that the IPSPs in (b) are abolished
(rightmost panel) by subsequent superfusion of bicuculline (Bic), verifying the mediation of IPSPs by GABAA receptor activation. (c, d) Averaged
evoked IPSP data from the two populations of CeA neurons showing opposite responses to galanin. (c) Galanin superfusion decreases the
mean IPSP amplitudes in one population of CeA neurons (n = 11) with partial recovery to baseline levels after galanin washout. (d) Galanin
increases IPSP amplitudes in another population of CeA neurons (n = 12) with recovery on washout. Dashed lines represent mean baseline
IPSP amplitudes prior to galanin superfusion
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antagonist, suggesting that this effect is the result of
GalR1 and/or GalR2 receptor activation. The lack of an
increase in IPSP amplitudes in the presence of the SNAP
antagonist again suggests it is the result of activation of
GalR3.
To tease out whether GalR1 or GalR2 is involved in
the IPSP depression, we tested CeA from mice with dele-
tion only of GalR2 receptors. Thus, in CeA neurons from
GalR2 KO mice, although we found some variability
from cell to cell, there was no significant decrease of
evoked IPSP amplitudes (n = 8; P = 0.15), even after
15 minutes of 1 mM galanin superfusion. However,
1 mM galanin robustly and significantly (n = 6;
P < 0.05) decreased mean IPSP amplitudes in CeA
neurons from the WT littermate mice (Fig. 5).
Thus, by exclusion, our data showing that the GalR3
antagonist greatly reduces the early IPSP increase often
seen in response to galanin, and that the more robust
IPSP decrease is greatly diminished in CeA neurons from
both GalR2 KO and the GalR1 ¥ GalR2 KO mice, suggest
that the IPSP decrease arises from activation of GalR2
receptors.
Ethanol interacts with galanin effects
Because of the suggested role of brain galanin in
ethanol intake (see Introduction), we also examined pos-
sible interactions of ethanol and galanin in mouse and
rat CeA neurons. Our previous studies of rat (Roberto
Figure 3 A GalR3 antagonist prevents the galanin increase of
inhibitory postsynaptic potential (IPSP) amplitudes in WT central
amygdala (CeA) neurons, but not the galanin-induced decrease. (a)
Representative voltage traces from a CeA neuron taken from a
normal WT mouse. In the presence of 200 nM SNAP 37889
(SNAP), superfusion of 1 mM galanin (14minutes) still depresses the
IPSP amplitude with recovery on washout of galanin (Wash;
14minutes). (b) Time course of mean IPSP amplitudes from a
pooled sample of five CeA neurons taken from normal WT mice.
Application of SNAP alone had little direct effect on mean IPSP
amplitudes but prevented 1 mM galanin-induced mean IPSP
amplitude increase. However, in the presence of SNAP, galanin
still significantly (P = 0.008; n = 5) decreased mean IPSP amplitudes.
Upper dashed line indicates baseline pre-treatment IPSP amplitudes.
Values are mean + standard error of the mean
Figure 4 In the presence of a GalR3 antagonist, galanin diminishes
central amygdala (CeA) inhibitory postsynaptic potentials (IPSPs) in
wild-type (WT) but not in GalR1 ¥GalR2 knockout (KO) mice. (a)
Time course of pooled intracellular IPSP data from CeA neurons of
GalR1 ¥GalR2 KO and control WT littermate mice. In CeA of WT
littermates, superfusion of the GalR3 antagonist SNAP 37889 (SNAP,
200 nM) alone slightly decreases mean IPSP amplitudes. Addition of
1 mM galanin (Gal) together with SNAP quickly and significantly
(P < 0.05) reduced IPSP amplitudes with recovery on washout. By
contrast, in CeA of GalR1 ¥ R2 KO mice superfusion of 1 mM galanin
with SNAP had no significant effect (P = 0.66) on evoked IPSP
amplitudes. Error bars = standard error of the mean. (b) Top row:
representative voltage traces from a CeA neuron of a WT mouse;
superfusion of 200 nM SNAP for 15minutes slightly decreases
the evoked IPSPs, and addition of 1 mM galanin for 10–11minutes
further reduces IPSP amplitude with recovery on washout (Wash;
16–17minutes). KCl electrode; resting membrane potential
(RMP) = -79mV. (b) Bottom row: representative-evoked IPSPs from
a CeA neuron of a GalR1 ¥ R2 KO mouse; superfusion of 200 nM
SNAP for 13–14minutes had little effect on IPSP amplitudes but the
double GalR KO apparently prevented the IPSP decrease usually
elicited by 12–13minutes of 1 mM galanin. KCl electrode;
RMP = -84mV
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et al. 2003, 2010b) and mouse (Nie et al. 2004, 2009;
Bajo et al. 2008) CeA neurons indicate that ethanol
reproducibly increases IPSP amplitudes, by increasing
GABA release, in most CeA neurons. In the present
studies, co-application of maximal concentrations for
these two agents (1 mM galanin, 44 mM ethanol)
resulted in a summation of effects only in a subpopula-
tion of neurons (cf. Figs 6 & 7), suggesting that galanin
and ethanol may interact on CeA GABAergic transmis-
sion via different cellular mechanisms. Thus, in a set of
12 CeA neurons from WT mice in which galanin
decreased IPSP amplitudes, ethanol applied together
with galanin only minimally reversed the IPSP ampli-
tude decrease (to 87% of control) elicited by galanin
alone (to 80%). Thus, galanin was somewhat preemp-
tive over the ethanol effects (Fig. 6a, b), because ethanol
alone generally augments CeA IPSPs to 130% or more
of control levels. Interestingly, in this group of CeA
neurons, both galanin and galanin with ethanol
increased PPF to the same extent in most cells (Fig. 6c),
similar to results with the GalR2 KOs, perhaps suggest-
ing decreased GABA release; however, this effect was not
statistically significant.
In seven WT mouse CeA neurons showing in-
creases of evoked IPSP amplitudes by galanin alone,
44 mM ethanol together with 1 mM galanin further
augmented the galanin effect by increasing IPSP
amplitudes to 137% of baseline (from 117%; Fig. 7a, b),
suggesting that ethanol and galanin effects involve
different mechanisms of action (e.g. presynaptic versus
postsynaptic) in this CeA population, with summa-
tion of maximal effects on IPSP size. Although again
galanin alone seemed to increase PPF, this effect was
not statistically significant; however, the differ-
ence between PPF during galanin alone and galanin
with ethanol (which decreases PPF) was significant
(Fig. 7c).
Of some interest is the rapid rebound reversal of
ethanol effects on IPSP size in both neuron groups (i.e.
showing either galanin-induced IPSP increases or
decreases) onwashout of the twoagents.We interpret this
rebound as resulting from a more rapid washout of
ethanol compared with galanin, with the galanin effect
persisting longer.
In a separate study (not shown), the co-perfusion of
galanin and ethanol onto CeA neurons of Sprague-
Dawley rats gave results equivalent to those in mouse
CeA: in the pooled data from four rat CeA neurons
showing galanin depression of IPSPs, ethanol
co-superfusion slightly reversed the galanin effect in
decreasingmean IPSP amplitudes, but only partially back
toward baseline, as in mouse CeA.
DISCUSSION
The widespread localization of galanin and its various
receptors in the amygdala (Melander et al. 1988; Kohler
et al. 1989a,b; Jhamandas et al. 1996; Mennicken et al.
2002; Jungnickel & Gundlach 2005; Lu et al. 2005b)
suggests that there are multiple cellular sites where the
neuropeptide may influence CeA neuronal function. For
example, the coexistence of galanin with noradrenaline
in the LC and CeA (and with serotonin in the DRN; Xu &
Hokfelt 1997) may suggest that galanin is involved in the
interactions between these two monoaminergic regions
that play key roles in mood regulation. In the case of the
CeA, these monoaminergic interactions with galanin
may influence the local GABAergic neurons known to
comprise most of the CeA population (Cassell et al. 1986,
1999). Despite the evidence of norepinephrine and
Figure 5 Galanin significantly decreases inhibitory postsynaptic
potential (IPSP) amplitudes in wild-type (WT) littermates but not in
GalR2 knockout (KO) mice. (a) Time course of pooled data from
GalR2 KO and littermate WT control mice; mean-evoked IPSP
amplitudes from central amygdala (CeA) neurons. Superfusion of
1 mM galanin (Gal) significantly decreases (P = 0.001; n = 9) the mean
IPSP amplitudes in CeA neurons fromWT controls with recovery on
washout. Superfusion of 1 mM Gal only slightly but insignificantly
(P = 0.23; n = 8) decreases mean IPSP amplitudes in CeA of GalR2
KO mice (error bars = standard error of the mean). (b)Top traces:
representative voltage records of a CeA neuron from a WT litter-
mate mouse; Gal superfusion for 12minutes diminishes the IPSPs
with recovery after 6minutes of washout [KCl electrode; resting
membrane potential (RMP) = -85mV]. Bottom traces: In a CeA
neuron of a GalR2 KO mouse, 14minutes of galanin superfusion had
little effect on IPSP amplitude (RMP = -86mV with KCl electrodes)
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Figure 6 Co-application of galanin prevents ethanol-dependent
augmentations of inhibitory postsynaptic potentials (IPSPs) in the
central amygdala (CeA) cells responding to galanin with a decrease
in IPSP amplitudes. (a) Time course of evoked IPSP responses of
multiple individual mouse CeA neurons to superfusion of 1 mM
galanin followed by co-superfusion of 44mM ethanol (+EtOH). (b)
Galanin decreased mean IPSP amplitudes by 20.0 3.4% in CeA
neurons (12 of 23 cells), and subsequent co-application of ethanol
(+EtOH) returned the IPSP amplitudes toward but below control
levels (to 87.3 7.0% of control).The lower horizontal bars corre-
spond to an average of the last 4minutes of galanin, galanin + ethanol
co-application and washout. Top panel: representative recordings
from an individual CeA neuron. (c) Both galanin and galanin + ethanol
co-application elicited increased paired-pulse facilitation (PPF) but
the increases did not reach statistical significance. Top panel: repre-
sentative recordings of PPF from an individual CeA neuron.The data
represent mean standard error of the mean % of control, and
asterisks denote significance at the P < 0.05 level (repeated analysis
of variance and Bonferroni post hoc test)
Figure 7 Co-superfusion of ethanol and galanin leads to additive
effects on evoked inhibitory postsynaptic potential (IPSP) amplitudes
in the cells responding to galanin with an increase in IPSP amplitudes.
(a) Time course of evoked IPSP responses of multiple individual
mouse central amygdala (CeA) neurons to superfusion of 1 mM
galanin followed by co-superfusion of 44mM ethanol (+EtOH). (b)
Galanin increased mean IPSP amplitudes (to 117 1.6% of baseline)
and subsequent co-application of ethanol further increased ampli-
tudes (to 136.7 10.3%) with brief recovery on washout, followed
by a rebound IPSP enhancement. Top panel: representative IPSP
recordings from an individual CeA neuron. (c) Although neither
galanin nor galanin + ethanol co-application significantly altered
paired-pulse facilitation (PPF) compared with control, there was a
significant decrease in PPF during galanin + ethanol co-application
compared with galanin alone (#, P < 0.05).Top panel: representative
recordings of PPF of IPSPs from an individual CeA neuron.The data
represent mean standard error of the mean % of control; statistical
significance, * and # corresponding to P < 0.05 and ** P < 0.01,
respectively, were calculated by repeated analysis of variance and
Bonferroni post hoc test.We interpret the washout rebound effects
as a more rapid washout of ethanol effects compared with galanin
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galanin coexistence in the CeA, the presence of multiple
galanin receptor subtypes there and behavioral effects
elicited by galanin microinjection into CeA (Moller et al.
1999; Khoshbouei et al. 2002), to our knowledge there
are no data available on the electrophysiological effects of
galanin in CeA neurons. Therefore, in the present study,
we first examined the effect of the neuropeptide galanin
and a GalR3-selective antagonist, in CeA neurons from
WT and GalR1 and GalR2 KO mice, on the electrophysi-
ological properties and GABAergic IPSPs of these
neurons.
In contrast to previous reports of hyperpolarizing
effects of galanin in DRN and several other neuron types
(Hokfelt et al. 1998; Xu et al. 1998a,b, 2001; Swanson
et al. 2005), galanin had no significant effect on current/
voltage relationships in CeA neurons. However, we found
that galanin clearly alters GABAergic neurotransmission
in CeA neurons, but in a cell- and receptor-dependent
manner. Interestingly, as with the effect of Gal 1-29 and
Gal 2-11 in decreasing the amplitudes of isolated GABAA-
IPSPs in most DRN neurons (Sharkey et al. 2008),
galanin (Gal 1-29) also decreased IPSP amplitudes in
many CeA neurons. However, in a large percentage of
CeA neurons, galanin measurably increased IPSP ampli-
tudes, albeit to a lesser extent than the decrease in IPSPs
seen in other cells. It should be noted that the long IPSP
depressions seen in some CeA neurons, like those
reported for Gal 1-29 decreases of IPSP amplitudes in
DRN neurons (Sharkey et al. 2008), persisted and even
increased over long application times, suggesting a stron-
ger late effect and a lack of tachyphalaxis in both CeA and
DRN neurons.
Our previous work on DRN neurons (Sharkey et al.
2008) suggested that the mechanisms whereby galanin
receptor agonists altered GABAergic transmission may
have depended on the receptor subtype activated: some
GalR receptor subtypes may have been activated in a
concentration-dependent manner such that longer expo-
sure to the neuropeptide (and perhaps greater slice pen-
etration) resulted in a greater effect. By contrast in CeA,
selective activation of some receptor types (e.g. GalR3)
may have a more transitory effect (e.g. increased IPSP
amplitudes), peaking at shorter exposure times before
desensitizing.
Furtherdifferences in theeffects of galanin inCeAwere
seen in the inconsistent or lack of effects onPPF, known to
be inversely related to neurotransmitter release (Menner-
ick & Zorumski 1995; Salin et al. 1996; Bonci &Williams
1997), except in CeA of GalR2 KO mice. In most CeA
neurons fromWT,GalR1 ¥ GalR2KOand littermatemice,
galanin had little effect on PPF in CeA neurons, although
CeA neurons of GalR2 KO mice showed galanin-evoked
PPF increases, suggesting a possible presynaptic action on
GalR1 and/or GalR3 receptors to regulate release of
GABA, whereas galanin at GalR2 receptors may act
postsynaptically. The localization of the GalR receptor
subtypes is not known, because of lackof antibodies selec-
tive for receptor subtypes, but our data may suggest that
some of the galanin receptors in the CeA may be on
GABAergic terminals,whereasmanycouldbeonpostsyn-
aptic elements (e.g. GPCRs, other signalling pathways)
that influence GABA receptor function.
The current study is the first to address the electro-
physiological effects of galanin on the GABAergic system
in the CeA. We have presented initial evidence for the
differential activation of the CeA galanin receptors GalR2
and GalR3 that may have important implications for the
development of novel galanin-based antidepressant or
anti-anxiety treatments. Previous work showed that
chronic antidepressant treatment (fluoxetine, 10 mg/kg
i.p. 14 days and electroconvulsive shock treatment
2 days) produced a shift in the GalR1 and GalR2 ratio
toward GalR2, as well as an elevation of galanin levels
(Lu et al. 2005a), suggesting that the galaninergic system
is affected by, and may be involved in, antidepressant
effects. Support for this idea is the recent finding thatmice
with a GalR2 KO show a more persistent depressive-like
phenotype than control WT mice (Lu et al. 2008). Differ-
ential activation of GalR2 and GalR3 by endogenous
galanin may shed light on the mechanisms by which this
antidepressant-induced change in GalR subtype ratio is
important in the clinical efficacy of antidepressant treat-
ments. Furthermore, the findings suggest that the devel-
opment of subtype-specific GalR agonists or antagonists
may be useful for novel antidepressant or anti-anxiety
treatments, as recently shown for GalR3 antagonists as
anti-anxiety agents (Swanson et al. 2005; Ogren et al.
2006; Lu et al. 2007).
In addition, our past (Nie et al. 2004; Roberto et al.
2010b) and present data may suggest that GalR2 activa-
tion or block of GalR3 favors reduction of GABAergic
inhibitory function in CeA neurons, perhaps resulting in
disinhibition of downstream GABAergic neurons (Bajo
et al. 2008), that may provide a mechanism underlying
this antidepressant action. Thus, the lack of an early
increase in IPSP amplitudes in the presence of the
SNAP antagonist suggests the increase is the result of
activation of GalR3. Notably, these galanin effects are
consistent with the anxiogenic/anxiolytic profile we have
recently hypothesized for the GABAergic neurons pre-
dominant in CeA, based on our findings over the last
5–6 years: anxiolytic-like agents such as opioid (Kang-
Park et al. 2007, 2009) and orphanin FQ (Roberto &
Siggins 2006) agonists (e.g. enkephalin and nociceptin)
and neuropeptide Y (NPY) and CB1 agonists (Roberto
et al. 2010a, Gilpinet al. 2011) function in CeA to reduce
presynaptic release of GABA, and thus should excite
these GABAergic inhibitory neurons by disinhibition. By
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contrast, the stress- and anxiety-related peptide CRF
increases evoked IPSP amplitudes, via presynaptic
increases in GABA release (Nie et al. 2004; Roberto et al.
2010b), and thus should counter the effects of the
‘anxiolytic-like’ agonists. Because most rodent CeA
neurons contain GABA (with various co-localized pep-
tides) and many of these GABA neurons project outside
the nucleus (e.g. to bed nucleus of stria terminalis), local
release of the opioids, nociceptin, NPY and cannabinoids
(and now galanin acting on GalR2 receptors) in CeA will
lead to the release of more GABA in downstream targets,
thus inhibiting these areas. As the extended amygdala is
known to be involved in stress-related disorders such as
anxiety, our combined findings may help to solve the
seeming paradox that anxiolytic-like substances reduce
rather than enhance, and ‘anxiogenic’ peptides increase,
GABAergic transmission within CeA: this CeA profile
would have opposite (i.e. more conventional) effects in
downstream areas like the bed nucleus of the stria termi-
nalis. The dual effects of galanin on GABAergic IPSPs in
CeA might then explain reports of mixed anxiolytic/
anxiogenic behavioral effects seen after microinjection of
galanin into CeA (Moller et al. 1999; Khoshbouei et al.
2002) and the anxiolytic-like effects of the GalR3 antago-
nists (Swanson et al. 2005; Ogren et al. 2006; Lu et al.
2007). The latter may reduce anxiety in part by antago-
nizing the GalR3 receptor-induced IPSP augmentation in
CeA, leaving behind the decrease of IPSPs elicited by
GalR2 receptors.
Notably, to date, ethanol was the only allegedly anxi-
olytic agent we tested that increased IPSP amplitudes in
CeA (Roberto et al. 2003, 2010b; Roberto & Siggins
2006). As noted earlier, the galanin augmentation of
IPSPs found in some CeA neurons suggests the activation
of GalR3 receptors, now thought to be involved in
anxiety. These considerations and emerging literature
suggesting a role for galanin and GalR2 receptors in
ethanol intake (Leibowitz et al. 2003; Lewis et al. 2004;
Chang et al. 2007; Karatayev et al. 2009, 2010) led us to
compare and assess possible interactions of ethanol with
galanin effects in CeA neurons. We indeed found such
interactions.These interactionswere suggestive of a sum-
mation of like effects only in neurons showing IPSP aug-
mentation by galanin. As no occlusive interactions
occurred in this population of neurons, we interpret the
summated interactions as indicating involvement of dif-
ferent cellular or molecular mechanisms for the two
agents in these cells. This interpretation is also supported
by the inconsistent or lack of significant alteration of PPF
by galanin in CeA of WT mice, in contrast to the PPF
decreases always associated with the increased presynap-
tic GABA release elicited by ethanol (Roberto et al. 2003,
2010b; Roberto & Siggins 2006). However, in those CeA
cells where galanin diminished IPSPs, there was only
slight summation of opposing effects by galanin plus
ethanol; this interaction (see Fig. 6) suggests that galanin
may have preemptive effects similar to those we previ-
ously found with nociceptin (Roberto & Siggins 2006).
The suggestion of PPF increases by galanin in these cells
may also indicate that ethanol and galanin act on the
same mechanism (e.g. GABA release) in this neuronal
population.
Further studies will be required to elucidate the exact
cellular sites of the galanin effects, the possible CeA
neuron types involved in the two galanin opposing effects
on GABAergic transmission reported here and the pos-
sible cellular role of CeA galanin in ethanol effects. With
respect to the latter, an important question is the effect of
endogenous galanin on discrete Gal receptors in CeA and
the effect of ethanol on the endogenous galanin-receptor
interactions. The type of study reported by Lu et al. 2010,
of the development of a putative GalR2-positive allosteric
modulator (CYM2503) that would act on GalR2 recep-
tors primarily via local endogenous galanin, may provide
a path to answer such a question for the CeA.
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